The prognosis of gout and hyperuricemia--the effect of the treatment on prognosis
Iwatani, M.; Nishioka, K.
Nihon Rinsho. Japanese Journal of Clinical Medicine 49(5): 1124-1130
1991
ISSN/ISBN: 0047-1852 PMID: 2067104 Document Number: 369342
Document emailed within 1 workday
Related Documents
Matulis, A.A.; Bareĭkene, I.P.; Venalis, A.I. 1987: Use of sorption for the correction of hyperuricemia in the combined treatment of gout Terapevticheskii Arkhiv 59(12): 17-19Gall, E.P. 1979: Hyperuricemia and gout. A modern approach to diagnosis and treatment Postgraduate Medicine 65(4): 163-7 170 172
Ohno, I.; Okabe, H.; Yamaguchi, Y.; Saikawa, H.; Uetake, D.; Hikita, M.; Gomi, H.; Ichida, K.; Hosoya, T. 2008: Usefulness of combination treatment using allopurinol and benzbromarone for gout and hyperuricemia accompanying renal dysfunction: kinetic analysis of oxypurinol Nihon Jinzo Gakkai Shi 50(4): 506-512
Matzkies, F. 1983: Therapy of hyperuricemia and gout. Effect of a combination therapy of allopurinol with benzbromarone Fortschritte der Medizin 101(20): 953-959
Kangas, T. 1971: The effect of treatment on the prognosis of diabetes mellitus Duodecim; Laaketieteellinen Aikakauskirja 87(2): 157-163
Kievit, J. 2002: The effect of treatment delay on the prognosis of breast cancer patients Nederlands Tijdschrift Voor Geneeskunde 146(22): 1031-1034
Peuke, C. 2010: Hyperuricemia/gout Medizinische Monatsschrift für Pharmazeuten 33(11): 429-432
Hirata, N.; Nakano, S.; Matsuda, H.; Taniguchi, K.; Sakaki, S.; Shintani, H.; Takahashi, T.; Mitsuno, M.; Ueda, T.; Kawashima, Y. 1992: The long-term prognosis of coronary artery bypass surgery--the influence of preoperative left ventricular volume on the prognosis of cardiac death Nihon Kyobu Geka Gakkai 40(2): 184-188
Hosoya, T. 2008: Gout and hyperuricemia: Introduction Nihon rinsho. Japanese journal of clinical medicine 66(4): 621-623
Sancho-Rieger, J.; López-Trigo, J. 2000: Prognosis of epilepsy and suppression of treatment. Prognosis of epilepsy Revista de Neurologia 30(4): 333-336
Roddy, E. 2008: Hyperuricemia, gout, and lifestyle factors Journal of Rheumatology 35(9): 1689-1691
Deray, G.; Assogba, U.; Le Hoang, P.; Brillet, G.; Baumelou, B.; Ben Hmida, M.; Jacobs, C. 1990: Cyclosporin induced hyperuricemia and gout Clinical Nephrology 33(3): 154
Ganzer, U.; Meyer-Breiting, E.; Ebbers, J.; Vosteen, K.H. 1982: Effect of tumor size on lymph node metastasis and type of treatment on the prognosis of hypopharyngeal cancer Laryngologie Rhinologie Otologie 61(11): 622-628
Roux, H.; Vovan, L.; Dutertre, P.; Serratrice, G.; Recordier, A.M. 1972: Lipid disorders in gout and in hyperuricemia with myalgia Marseille Medical 109(10): 609-625
Stĕpán, J.; Sváb, V.; Kolár, J.; Susta, A.; Cáp, F. 1983: The spine and polytopic hyperostoses in gout and hyperuricemia Der Radiologe 23(8): 371-374
Imanishi, M.; Ikegami, M.; Ishii, T.; Nishioka, T.; Uemura, T.; Kunikata, S.; Kanda, H.; Matsuura, T.; Akiyama, T.; Kurita, T. 1990: Clinical studies on hyperuricemia and gout after transplantation Hinyokika Kiyo. Acta Urologica Japonica 36(8): 893-896
Lindsley, H.B. 1978: Hyperuricemia and gout: eminently treatable disorders Journal of the Kansas Medical Society 79(11): 614-617
Hayakawa, K.; Mitsuhashi, N.; Saito, Y.; Takahashi, M.; Katano, S.; Shiojima, K.; Furuta, M.; Niibe, H. 1993: Effect of krestin (PSK) as adjuvant treatment on the prognosis after radical radiotherapy in patients with non-small cell lung cancer Anticancer Research 13(5c): 1815-1820
Fadieieva, A.; Prystupa, L.; Pogorelova, O.; Kirichenko, N.; Dudchenko, I. 2016: Role of Slc2a9 and Abcg2 Gene Polymorphisms in Origin of Hyperuricemia and Gout Georgian Medical News 252: 79-83
Kohkhar, N. 1980: Hyperuricemia and gout in secondary polycythemia due to chronic obstructive pulmonary disease Journal of Rheumatology 7(1): 114-116